AB
KZR

Amalgamated Bank’s Kezar Life Sciences KZR Stock Holding History

Amalgamated Bank’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-163
Closed -$1K – 3068
2024
Q1 		$1K Sell
163
-489
-75% -$4.45K ﹤0.01% 2919
2023
Q4 		$6K Sell
652
-48
-7% -$422 ﹤0.01% 2928
2023
Q3 		$8K Buy
700
+181
+35% +$3.21K ﹤0.01% 2930
2023
Q2 		$13K Hold
519
– – ﹤0.01% 2909
2023
Q1 		$16K Sell
519
-129
-20% -$7.46K ﹤0.01% 2719
2022
Q4 		$46K Hold
648
– – ﹤0.01% 2452
2022
Q3 		$56K Buy
648
+57
+10% +$5.54K ﹤0.01% 2407
2022
Q2 		$49K Buy
591
+170
+40% +$15K ﹤0.01% 2493
2022
Q1 		$70K Buy
+421
New +$60.4K ﹤0.01% 2317

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Amalgamated Bank's KZR Position: Q2 2024 in Review

Amalgamated Bank sold out of Kezar Life Sciences (KZR) in Q2 2024, closing a stake of 163 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in KZR in Q1 2022 and held it in 9 quarters. The position peaked at $70K in Q1 2022. 81 funds tracked by Wall St. Rank hold KZR as of Q2 2024.

  • Amalgamated Bank reported no remaining Kezar Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 163 Kezar Life Sciences shares in Q2 2024, an estimated $1K.
  • Amalgamated Bank first reported a position in Kezar Life Sciences in Q1 2022 and held it in 9 quarters.
  • Amalgamated Bank's Kezar Life Sciences position peaked at $70K in Q1 2022.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.